Biomapas Achieves Notable Recognition with Nomination for HSJ Patient Safety Awards 2023

PRESS RELEASE

Biomapas Achieves Notable Recognition with Nomination for HSJ Patient Safety Awards 2023

[Vilnius, Lithuania]– Biomapas, a global leader in life sciences solutions, has proudly announced its commendable nomination at the revered HSJ Patient Safety Awards 2023. This significant recognition is attributed to the company's collaborative endeavor with the Pathfinder Risk Management Platform – A National Pregnancy Prevention Programme for generic Lenalidomide.

The project has successfully secured nominations in two esteemed categories:

• Safety Improvements Through Technology
• Improving Medicines' Safety

In this initiative, Biomapas has been identified as having played a pivotal role, joining forces with their esteemed partner, Pharmacare Group. Their efforts were primarily centered on pioneering the development of an integral quality management system crucial to the Pathfinder platform's administration. Moreover, Biomapas's commitment to patient safety and regulatory compliance as an early phase cro services company was further accentuated by their provision of independent QPPV (Qualified Person for Pharmacovigilance) oversight throughout the project's lifecycle.

This notable nomination is a testament to the collaborative spirit shared by NHS England, the Medicines and Healthcare products Regulatory Agency, British Generics Manufacturers Association, PharmaCare Group Ltd (PCG), and HealthBeacon. The nomination speaks volumes about the power of collaborative innovation, especially when entities come together with a shared goal to enhance patient safety.

The HSJ Patient Safety Awards are renowned for recognizing and celebrating efforts that aim to elevate culture and quality across the NHS and the healthcare sector at large. The awards stand as a tribute to those teams and individuals who persistently push the boundaries to improve patient care, even in the face of challenges such as austerity, pay restraints, and workforce shortages.

A key figure in driving this initiative's success from Biomapas's end has been Artemis Thanasopoulou. Her leadership and dedication have been instrumental in steering the project towards its objectives. Furthermore, the trust and collaboration of PharmaCare Group Ltd (PCG) have been invaluable in bringing this initiative to fruition. As Biomapas garners this recognition, it is clear that their collective efforts are setting new standards in the realm of patient safety and care. This nomination serves as a beacon of their commitment to healthcare excellence.